Table 4 Total incidence counts and annual percentage change (APC) in incidence rates of childhood cancer by diagnostic group and sex, Australia, 1983–2006a,b
From: Trends in incidence of childhood cancer in Australia, 1983–2006
Trend 1 | Trend 2 | Trend 3 | |||||
|---|---|---|---|---|---|---|---|
Diagnostic group | Total number of cases | Years | APC (95% CI) | Years | APC (95% CI) | Years | APC (95% CI) |
All children | |||||||
All cancers | 13 925 | 1983–1994 | +1.7 (+0.9,+2.5) | 1994–2006 | −0.1 (−0.7,+0.6) | ||
0–4 years | 6454 | 1983–2006 | +0.7 (+0.3, +1.1) | ||||
5–9 years | 3525 | 1983–2006 | +0.5 (−0.1, +1.1) | ||||
10–14 years | 3946 | 1983–1996 | +2.7 (+1.1, +4.2) | 1997–2006 | −1.4 (−3.3, +0.7) | ||
Leukaemias | 4591 | 1983–2006 | +0.9 (+0.3,+1.5) | ||||
Lymphomas | 1374 | 1983–2006 | +0.7 (+0.0,+1.3) | ||||
CNS | 3158 | 1983–1998 | +1.7 (+0.6,+2.8) | 1998–2006 | −1.8 (−4.5,+1.0) | ||
Neuroblastomas | 869 | 1983–2006 | +0.2 (−1.1,+1.4) | ||||
Retinoblastomas | 357 | 1983–2006 | +0.1 (−1.1,+1.4) | ||||
Renal tumours | 735 | 1983–2006 | +0.4 (−0.7,+1.6) | ||||
Hepatic tumours | 174 | 1983–2006 | +3.3 (+0.8,+5.9) | ||||
Malignant bone tumours | 602 | 1983–2006 | +0.3 (−0.8,+1.3) | ||||
Soft tissue sarcomas | 820 | 1983–2006 | −0.2 (−1.4,+1.1) | ||||
Germ cell tumours | 511 | 1983–2006 | +2.3 (+0.9,+3.7) | ||||
Malignant epithelial tumours and melanoma | 705 | 1983–1996 | +4.3 (+1.6,+7.0) | 1996–2006 | −5.7 (−9.1,−2.2) | ||
Boys | |||||||
All cancers | 7684 | 1983–1994 | +1.6 (+0.8,+2.4) | 1994–2006 | −0.4 (−1.0,+0.3) | ||
Leukaemias | 2545 | 1983–2006 | +0.6 (+0.1,+1.2) | ||||
Lymphomas | 960 | 1983–2006 | +0.5 (−0.3,+1.3) | ||||
CNS | 1685 | 1983–2006 | +0.7 (−0.1,+1.5) | ||||
Neuroblastomas | 483 | 1983–1994 | +3.0 (−0.8,+7.0) | 1994–2006 | −4.1 (−7.4,−0.6) | ||
Retinoblastomas | 211 | 1983–2006 | +0.1 (−1.7,+2.0) | ||||
Renal tumours | 336 | 1983–2006 | +0.1 (−1.6,+1.8) | ||||
Hepatic tumours | 106 | 1983–2006 | +3.7 (+0.5,+7.0) | ||||
Malignant bone tumours | 319 | 1983–2006 | +0.1 (−1.3,+1.6) | ||||
Soft tissue sarcomas | 452 | 1983–2006 | −0.5 (−2.0,+1.1) | ||||
Germ cell tumours | 253 | 1983–2006 | +2.6 (+0.8,+4.5) | ||||
Malignant epithelial tumours and melanoma | 318 | 1983–1996 | +4.3 (−0.7,+9.5) | 1996–2006 | −7.0 (−13.0,−0.6) | ||
Girls | |||||||
All cancers | 6241 | 1983–2006 | +0.9 (+0.5,+1.4) | ||||
Leukaemias | 2046 | 1983–2006 | +1.3 (+0.8,+1.9) | ||||
Lymphomas | 414 | 1983–2006 | +1.2 (−0.2,+2.5) | ||||
CNS | 1473 | 1983–2006 | +0.5 (−0.3,+1.4) | ||||
Neuroblastomas | 386 | 1983–2006 | +1.3 (−0.5,+3.1) | ||||
Retinoblastomas | 146 | 1983–2006 | −0.5 (−2.4,+1.4) | ||||
Renal tumours | 399 | 1983–2006 | +0.7 (−0.7,+2.1) | ||||
Hepatic tumours | 68 | 1983–2006 | +2.5 (+0.0,+5.0) | ||||
Malignant bone tumours | 283 | 1983–2006 | +0.5 (−1.0,+2.0) | ||||
Soft tissue sarcomas | 368 | 1983–1992 | +7.7 (+0.8,+15.1) | 1992–1999 | −8.0 (−18.0,+3.2) | 1999–2006 | +5.5 (−3.0,+14.9) |
Germ cell tumours | 258 | 1983–2006 | +2.0 (+0.2,+3.9) | ||||
Malignant epithelial tumours and melanoma | 387 | 1983–2006 | +0.5 (−1.3,+2.5) | ||||
